LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10313 | 10362 | 0.9951 | 0.9976 |
MCF 10A | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 513 | 10064 | 10362 | 0.9712 | 0.9866 |
MCF 10A | CP724714 | 10 | uM | LJP5 | 72 | hr | 513 | 9029 | 10362 | 0.8713 | 0.9373 |
MCF 10A | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 513 | 486 | 10473 | 0.0464 | -0.0146 |
MCF 10A | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 513 | 452 | 10473 | 0.0432 | -0.0298 |
MCF 10A | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10313 | 10362 | 0.9953 | 0.9978 |
MCF 10A | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 513 | 9976 | 10362 | 0.9629 | 0.9824 |
MCF 10A | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 513 | 9610 | 10362 | 0.9278 | 0.9654 |
MCF 10A | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 513 | 8627 | 10362 | 0.8327 | 0.9169 |
MCF 10A | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7852 | 10473 | 0.7495 | 0.8710 |
MCF 10A | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 513 | 995 | 10473 | 0.0950 | 0.1636 |
MCF 10A | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 513 | 665 | 10473 | 0.0636 | 0.0613 |
MCF 10A | AT-7519 | 10 | uM | LJP6 | 72 | hr | 513 | 482 | 10473 | 0.0461 | -0.0150 |
MCF 10A | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1722 | 10473 | 0.1645 | 0.3189 |
MCF 10A | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 513 | 936 | 10473 | 0.0894 | 0.1480 |
MCF 10A | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 513 | 2503 | 10473 | 0.2388 | 0.4339 |
MCF 10A | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 513 | 1215 | 10473 | 0.1160 | 0.2178 |
MCF 10A | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 513 | 927 | 10473 | 0.0885 | 0.1425 |
MCF 10A | AZD8055 | 10 | uM | LJP6 | 72 | hr | 513 | 840 | 10473 | 0.0802 | 0.1194 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 513 | 10401 | 10473 | 0.9931 | 0.9965 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 513 | 10330 | 10473 | 0.9863 | 0.9936 |
MCF 10A | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10964 | 10362 | 1.0581 | 1.0262 |
MCF 10A | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10725 | 10362 | 1.0350 | 1.0159 |
MCF 10A | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 513 | 6501 | 10473 | 0.6206 | 0.7920 |
MCF 10A | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 513 | 9055 | 10473 | 0.8647 | 0.9335 |